“The Buzz” Show: Plus Therapeutics (NASDAQ: PSTV) Awarded USD 17.6 Million from State of Texas
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Plus Therapeutics Awarded $17.6 Million from State of Texas” Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, announced that it was awarded a $17.6 million Product Development Research grant by the Cancer …